ViroMed Co. Ltd. | Ownership
Companies that own ViroMed Co. Ltd.
The Vanguard Group, Inc.
345,509
2.17%
25,798
0%
07/31/2018
BlackRock Fund Advisors
310,036
1.94%
331
0%
09/06/2018
Norges Bank Investment Management
142,209
0.89%
-93,663
0%
12/31/2017
APG Asset Management NV
58,288
0.37%
523
0.01%
03/31/2018
BlackRock Advisors (UK) Ltd.
57,902
0.36%
0
0.01%
09/06/2018
Mirae Asset Global Investments Co., Ltd.
28,033
0.18%
5,483
0.05%
04/30/2018
Parametric Portfolio Associates LLC
24,612
0.15%
0
0%
06/30/2018
Sjunde AP-fonden
22,263
0.14%
22,263
0.01%
06/29/2018
Geode Capital Management LLC
21,359
0.13%
799
0%
09/11/2018
Credit Suisse Asset Management (Schweiz) AG
15,343
0.1%
0
0.01%
07/31/2018
| Address |
203 Bldg. Natural Science College
Seoul SL 08733
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.viromed.co.kr |
| Updated |
09/14/2018 |
| ViroMed Co., Ltd. engages in the development and manufacture of biopharmaceuticals for human diseases. It operates through the Natural Materials and Biomedical Products Business Divisions. Its products include technologies for diseases. |
